Lexicon Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $371.8M
Liabilities Breakdown FY2012
Total Liabilities: $105.1M
Asset Breakdown
Total Assets: $371.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.4M | 8.2% |
| Accounts Receivable | $1.4M | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $42.6M | 11.5% |
| Goodwill | $44.5M | 12.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $252.8M | 68.0% |
Liabilities Breakdown
Total Liabilities: $105.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.7M | 7.3% |
| Long-Term Debt | $21.9M | 20.8% |
| Other Liabilities | $75.6M | 71.9% |